Stocktwits on MSN
Why is HOTH stock up 70% after-hours today?
HT-VA outperformed Danish drug Novo Nordisk’s blockbuster semaglutide drug in key gene expression markers tied to liver fat regulation, the company said. ・The company is now looking to advance the ...
Hoth Therapeutics Inc. (NASDAQ: HOTH) on Wednesday announced the deployment of the OpenAI API to support IND-enabling development of HT-KIT, targeting rare and aggressive KIT-driven cancers. The ...
Stocktwits on MSN
REPL, HOTH, ONCO stocks hit 52-week lows: What's driving the selloff in these biotech plays?
REPL came under pressure after the FDA issued a second Complete Response Letter for RP1 with nivolumab in anti-PD-1-failed melanoma. ・HOTH declined after a $2 million stock offering, along with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results